Journal article
Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation
Abstract
BACKGROUND: Oral anticoagulants (OAC) in patients with atrial fibrillation (AF) prevent thromboembolic events, but are associated with significant risk of bleeding.
OBJECTIVES: To explore associations between a wide range of biomarkers and bleeding risk in patients with AF on OAC.
Authors
Siegbahn A; Lindbäck J; Hijazi Z; Åberg M; Alexander JH; Eikelboom JW; Lopes RD; Pol T; Oldgren J; Granger CB
Journal
Journal of Thrombosis and Haemostasis, Vol. 19, No. 11, pp. 2726–2737
Publisher
Elsevier
Publication Date
11 2021
DOI
10.1111/jth.15498
ISSN
1538-7933